Reference drugs for triple combination test drug in Russia [Design Issues]

posted by PharmCat  – Russia, 2019-11-16 17:22  – Posting: # 20812
Views: 912

» Generic companies did develop almost all attractive double combinations for cardiovasulcar diseases and were trying to expand to triple combinations.

And all this at the moment is a offense against the law.

Complete thread:

 Admin contact
20,103 posts in 4,243 threads, 1,382 registered users;
online 13 (1 registered, 12 guests [including 9 identified bots]).
Forum time (Europe/Vienna): 07:27 CET

We must be careful not to confuse data with the abstractions
we use to analyze them.    William James

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz